Tiziana Life Sciences Share Discussion Threads

[rebelwithacause1] 19/1/2021 13:50

I too am keeping my powder dry buddy...it will struggle to get anywhere near 200p without any effectual success and even that is not guaranteed...as I said now is the time to be very careful.

[yidarmytom] 19/1/2021 13:45

busy sitting on my hands while watching the lunatics on Twitter & some on LSE with crazy stock price predictions.

[rebelwithacause1] 19/1/2021 13:38

'Direction of travel' is with the US not the UK Tom...but equilibrium between both listings seems about right...
Crazy to be lured into false Price/Action presently but maybe 'Money' does grow on trees!

[yidarmytom] 19/1/2021 13:35

or maybe adr's have further to rise, or maybe both, this falls adr's rise and they meet in the middle. although the MM's can do some dodgy dealing between the 2 order books.

[rebelwithacause1] 19/1/2021 13:31

This has got further to fall yet before equilibrium between listings...becareful.

[lean5gb] 19/1/2021 13:20

....... Noted Reb.

[rebelwithacause1] 19/1/2021 13:04

Please don't listen to these 'Foolish Investors' on LSE, they cannot be objective too all things 'Tils'...And you will lose your hard-earned readies...

[yidarmytom] 19/1/2021 12:31

agree 150% there pal

[rebelwithacause1] 19/1/2021 11:58

No beef, but i don't enjoy being undermined by foolish investors that believe in anything apart from the 'Science' - if you get my drift buddy...But I do feel for those that have been lured into to the higher price action, which I clearly stated was uninviting!

[yidarmytom] 19/1/2021 11:54

lovin the beef on this Board, wonderful stuff!! ya'll keep it goin ;o-)))

[rebelwithacause1] 19/1/2021 11:50

Hehe, we all know who 'OldApaches' namesake is on ADvfn!

As it was expected, the masses are disappointed yet again...but please dont let the 'Champ' tell you otherwise!

By the way Lean, I was just responding to comments on LSE...

[andymunchkin] 19/1/2021 11:49

NotMyFault RampngCntsR selling

[andymunchkin] 19/1/2021 11:48

NothingPersonal markyMark

[markstevenkirby80] 19/1/2021 11:37

Good morning my little munchkin

[andymunchkin] 19/1/2021 11:32

ForLambs toSlaughter

[andymunchkin] 19/1/2021 11:30

Freefall ursTruly allBuTT ArThur

[mark0419] 19/1/2021 11:25

Taken from LSE BOARD. I WISH........ Imminent top line covid news!.. Could attract massive investment.... share price will rise very quick with minimal shares in issue.New chief medical officer from Regeneron tells me it must be good results for him to come to TILS.Eyes on us from biotech conference and JPMorgan conference recently... Matter of time for large investors to jump on?Price targets of 11 dollars!..... Short term and if this covid result is very positive the share price genuinely could go up to £10 plus.We have all seen NCYT rise from penny's to over £10.It's always impossible till its done. Go and ask NCYT investors....Look at he credentials working on this company.Foralumab.....potentially game changing.... As quoted by the new CMO himself.

[yidarmytom] 19/1/2021 11:16

we know that Tiziana likes an intra-day RNS, could drop at any time folks

[mark0419] 19/1/2021 11:08

Andy muppet..,. come in why don't you. What gem's of wisdom are you going to bestow apon us today. We are all ears whilst it's so quiet on the board.

[andymunchkin] 19/1/2021 10:23

Mark041915 Jan '21 - 10:17 - 12165 of 12263
0 0 0
You'll be saying oldapche is andymunchkin by the end of the day. Unbelievable.
———;——̵2;—
Not

[yidarmytom] 19/1/2021 10:11

not exactly frenzied buying prior to the Covid trial data and the Main Market Listing! Very low volume today.

[mark0419] 19/1/2021 09:35

It's strange but there are a few on our board/currently in their boardroom.Hope we get a price action similar to OKYO this week.

[yidarmytom] 19/1/2021 09:29

it seems a stretch to be jumping on the Covid bandwagon with a dry eye treatment

[mark0419] 19/1/2021 09:26

Gabriele Cerrone (age: 48)Mr Cerrone has a successful track record and extensive experience in the financing and restructuring of micro-cap biotechnology companies. He has founded ten biotechnology companies in oncology, infectious diseases and molecular diagnostics, and has taken seven of these companies to the NASDAQ Market and two to the Main Market and AIM Market in London. Mr Cerrone is Executive Chairman of dual listed Tiziana Life Sciences plc. Mr Cerrone co-founded Cardiff Oncology, Inc. (NASDAQ: CRDF), an oncology company and served as its Co-Chairman; he was a co-founder and served as Chairman of both Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) and Callisto Pharmaceuticals, Inc. (OTCMKTS: CLSP), and was a Director of and led the restructuring of Siga Technologies, Inc. (NASDAQ: SIGA). Mr Cerrone also co-founded FermaVir Pharmaceuticals, Inc. and served as Chairman of the Board until its merger in September 2007 with Inhibitex, Inc. Mr Cerrone served as a director of Inhibitex, Inc. until its US$2.5bn sale to Bristol Myers Squibb Co in 2012.

[mark0419] 19/1/2021 09:20

WHO KNEW..... Sister company OKYO release RNS treatment to treat COVID-19 and ARDS patients this may cause some price action this morning.Tils & Okyo teamshttp://www.tizianalifesciences.com/about-us/our-teamhttps://www.okyopharma.com/about-us5 from 7 of the Okyo team are on the Tils team.sister company ?Gabriele Cerrone is the non. exec chairman .recently appointed ?